Figure 5
Decision curve analysis of nomogram model for predicting PFS and OS of oligometastatic EC patients. The dash line represents the net benefit of nomogram model. (A) Decision curve analysis of nomogram models for predicting 6-month PFS of oligometastatic EC patients. The gray and black lines represent that no patients and all patients would progress, respectively. (B) Decision curve analysis of nomogram models for predicting 12-month survival of oligometastatic EC patients. The gray and black lines represent that no patients and all patients would die, respectively. PFS, progression free survival; OS, overall survival; EC, esophageal cancer.
